Nuedexta, a drug originally developed at CNS, was advertised on the cover of July issue of People Magazine.
top of page
Goghy Stokin
News
June 5, 2012 – At the invitation of ALS Association and NEALS, Dr. Smith discussed the scientific basis for an upcoming ALS clinical trial in a webinar entitled: "Determining the Effect of Nuedexta on Speech and Swallowing in ALS: A Multicenter Trial"
February 17, 2012 – Dr. Smith spoke at Cedar-Sinai in Los Angeles.
March 8, 2012 – Dr. Smith spoke at the Packard Conference in John Hopkins.
FDA approves Nuedexta which was discovered at CNS and developed by Avanir pharmaceutical corporation.
bottom of page